A phase I trial of escalating doses of cixutumumab (IMC-A12) and sorafenib in the treatment of advanced hepatocellular carcinoma

Anthony B. El-Khoueiry, Robert O’Donnell, Thomas J. Semrad, Philip Mack, Suzette Blanchard, Nathan Bahary, Yixing Jiang, Yun Yen, John Wright, Helen Chen, Heinz Josef Lenz, David R. Gandara

研究成果: 雜誌貢獻文章同行評審

5 引文 斯高帕斯(Scopus)

指紋

深入研究「A phase I trial of escalating doses of cixutumumab (IMC-A12) and sorafenib in the treatment of advanced hepatocellular carcinoma」主題。共同形成了獨特的指紋。

Medicine & Life Sciences

Chemical Compounds